Teva Pharmaceutical Industries (TEVA) Prepaid Assets (2009 - 2026)

Teva Pharmaceutical Industries (TEVA) posted quarterly Prepaid Assets of $1.1 billion for Q1 2026, up 5.11% year-on-year from $1.0 billion in Q1 2025, and down 4.63% on a QoQ basis from $1.1 billion in Q4 2025.

Teva Pharmaceutical Industries (TEVA) Prepaid Assets (2009 - 2026) Analysis & Trends

Teva Pharmaceutical Industries (TEVA) has reported Prepaid Assets for 18 consecutive years, with $1.1 billion the latest figure, recorded in Q1 2026.

  • Quarterly Prepaid Assets rose 5.11% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 5.11% YoY) and the FY2025 annual result came in at $1.1 billion, up 11.53% from the prior year.
  • Prepaid Assets eased to $1.1 billion in Q1 2026 per TEVA's latest filing, from $1.1 billion in the prior quarter.
  • Over the last five years, Prepaid Assets for TEVA reached as high as $1.3 billion in Q1 2024 and fell as low as $1.0 billion in Q4 2024.
  • A 5-year average of $1.1 billion and a median of $1.1 billion in 2025 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2023 — Prepaid Assets grew 17.76% — and 2025, when it dropped 23.8%.
  • Year by year, Prepaid Assets stood at $1.2 billion in 2022, then gained by 8.0% to $1.3 billion in 2023, then fell by 19.84% to $1.0 billion in 2024, then advanced by 11.53% to $1.1 billion in 2025, then fell by 4.63% to $1.1 billion in 2026.
  • According to Business Quant data, Prepaid Assets over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 87.22 Bn 85.35 Bn -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.07 Bn
Dec 31, 2025 1.12 Bn
Sep 30, 2025 1.12 Bn
Jun 30, 2025 1.08 Bn
Mar 31, 2025 1.02 Bn
Dec 31, 2024 1.01 Bn
Sep 30, 2024 1.13 Bn
Jun 30, 2024 1.10 Bn
Mar 31, 2024 1.34 Bn
Dec 31, 2023 1.26 Bn
Sep 30, 2023 1.17 Bn
Jun 30, 2023 1.23 Bn
Mar 31, 2023 1.25 Bn
Dec 31, 2022 1.16 Bn
Sep 30, 2022 1.05 Bn
Jun 30, 2022 1.05 Bn
Mar 31, 2022 1.06 Bn
Dec 31, 2021 1.08 Bn
Sep 30, 2021 1.07 Bn
Jun 30, 2021 1.02 Bn